Intersect ENT, Inc. (XENT) Social Stream
Intersect ENT Inc (XENT) Price Targets From Analysts
Use the tables below to see what analysts covering Intersect ENT Inc think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 6 | $28.25 | $10 | $25.21 | $27.06 | -6.84% |
The Trend in the Analyst Price Target
XENT's average price target has moved up $4.58 over the prior 39 weeks.
XENT reports an average of 6.02% for its upside potential over the past 17 months.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-20 | 6 | 28.25 | 10 | 25.21 | 27.10 | -6.97% |
| 2021-09-19 | 6 | 28.25 | 10 | 25.21 | 27.25 | -7.49% |
| 2021-09-18 | 6 | 28.25 | 10 | 25.21 | 27.25 | -7.49% |
| 2021-09-11 | 6 | 28.25 | 10 | 25.21 | 27.06 | -6.84% |
| 2021-09-04 | 6 | 28.25 | 10 | 25.21 | 27.53 | -8.43% |
| 2021-08-19 | 6 | 28.25 | 10 | 25.21 | 27.40 | -7.99% |
| 2021-08-14 | 6 | 28.25 | 10 | 25.21 | 27.51 | -8.36% |
| 2021-08-07 | 7 | 32.00 | 10 | 25.39 | 27.37 | -7.23% |
| 2021-08-05 | 7 | 32.00 | 10 | 23.29 | 24.52 | -5.02% |
| 2021-08-01 | 7 | 32.00 | 10 | 23.29 | 23.35 | -0.26% |
| 2021-07-24 | 7 | 32.00 | 10 | 23.29 | 20.01 | 16.39% |
| 2021-07-17 | 7 | 32.00 | 10 | 23.29 | 18.60 | 25.22% |
| 2021-07-10 | 7 | 32.00 | 10 | 23.29 | 19.50 | 19.44% |
| 2021-07-01 | 7 | 32.00 | 10 | 23.29 | 18.11 | 28.6% |
| 2021-06-26 | 7 | 32.00 | 10 | 23.29 | 16.49 | 41.24% |
| 2021-06-13 | 7 | 32.00 | 10 | 23.00 | 16.54 | 39.06% |
| 2021-06-05 | 7 | 32.00 | 10 | 23.00 | 16.46 | 39.73% |
| 2021-05-22 | 7 | 32.00 | 10 | 23.00 | 18.04 | 27.49% |
| 2021-05-15 | 7 | 32.00 | 10 | 23.00 | 17.66 | 30.24% |
| 2021-05-08 | 7 | 32.00 | 10 | 23.71 | 21.04 | 12.69% |
| 2021-04-25 | 7 | 32.00 | 10 | 23.71 | 21.17 | 12% |
| 2021-04-17 | 7 | 32.00 | 10 | 23.71 | 19.98 | 18.67% |
| 2021-04-10 | 7 | 32.00 | 10 | 24.00 | 20.49 | 17.13% |
| 2021-04-03 | 7 | 32.00 | 10 | 24.00 | 20.99 | 14.34% |
| 2021-03-20 | 7 | 32.00 | 10 | 24.00 | 20.28 | 18.34% |
| 2021-03-13 | 7 | 32.00 | 10 | 24.00 | 22.40 | 7.14% |
| 2021-03-06 | 8 | 32.00 | 10 | 23.00 | 23.82 | -3.44% |
| 2021-02-27 | 8 | 32.00 | 10 | 23.00 | 22.81 | 0.83% |
| 2021-02-20 | 8 | 32.00 | 10 | 23.00 | 24.37 | -5.62% |
| 2021-02-13 | 8 | 32.00 | 10 | 23.00 | 25.35 | -9.27% |
| 2021-02-06 | 8 | 32.00 | 10 | 23.00 | 24.07 | -4.45% |
| 2021-01-30 | 8 | 32.00 | 10 | 23.00 | 22.47 | 2.36% |
| 2021-01-23 | 8 | 32.00 | 10 | 22.50 | 26.60 | -15.41% |
| 2021-01-16 | 8 | 32.00 | 10 | 22.50 | 23.98 | -6.17% |
| 2021-01-07 | 8 | 32.00 | 10 | 20.63 | 21.63 | -4.62% |
| 2020-12-30 | 8 | 32.00 | 10 | 20.63 | 22.71 | -9.16% |
| 2020-12-26 | 8 | 32.00 | 10 | 20.63 | 23.00 | -10.3% |
| 2020-12-19 | 8 | 32.00 | 10 | 20.63 | 21.73 | -5.06% |
| 2020-12-09 | 8 | 32.00 | 10 | 20.63 | 21.75 | -5.15% |
| 2020-12-07 | 8 | 32.00 | 10 | 20.63 | 21.42 | -3.69% |
| 2020-11-28 | 8 | 32.00 | 10 | 20.13 | 20.25 | -0.59% |
| 2020-11-17 | 8 | 32.00 | 10 | 20.12 | 18.56 | 8.41% |
| 2020-11-02 | 7 | 30.00 | 10 | 18.43 | 15.96 | 15.48% |
| 2020-10-21 | 7 | 30.00 | 10 | 18.50 | 15.54 | 19.05% |
| 2020-09-21 | 7 | 30.00 | 10 | 18.93 | NA | NA% |
| 2020-08-06 | 6 | 30.00 | 16 | 20.42 | NA | NA% |
| 2020-07-25 | 5 | 18.50 | 13 | 15.50 | NA | NA% |
| 2020-07-14 | 6 | 18.50 | 10 | 14.58 | NA | NA% |
| 2020-06-29 | 6 | 18.00 | 10 | 13.83 | NA | NA% |
| 2020-06-13 | 6 | 18.00 | 10 | 14.00 | NA | NA% |
| 2020-05-12 | 6 | 18.00 | 10 | 14.00 | NA | NA% |
XENT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.06 | 0 | 0 | 7 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
XENT's average broker recommendation rating worsened by 0.87 over the prior 18 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for XENT as an investment opportunity.
- Intersect ENT Inc's variance in analysts' estimates is lower than 11.72% of all US stocks.
- XENT has a higher upside potential (average analyst target price relative to current price) than 5.75% of Healthcare stocks.
- The number of analysts covering the stock of XENT is greater than 79.37% of stocks in the small market cap category.
- Intersect ENT Inc's average analyst price target is greater than 61.34% of stocks in the small market cap category.
Stocks similar to Intersect ENT Inc in the Medical Equipment industry regarding analyst recommendations and price targets are IRTC, SDC and INO.
Make investment decisions regarding XENT using the data that counts. Try POWR Ratings for free.